These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

1574 related articles for article (PubMed ID: 18490657)

  • 21. Characterization of HIV-1 envelopes in acutely and chronically infected injection drug users.
    Etemad B; Gonzalez OA; White L; Laeyendecker O; Kirk GD; Mehta S; Sagar M
    Retrovirology; 2014 Nov; 11():106. PubMed ID: 25430652
    [TBL] [Abstract][Full Text] [Related]  

  • 22. Infant transmitted/founder HIV-1 viruses from peripartum transmission are neutralization resistant to paired maternal plasma.
    Kumar A; Smith CEP; Giorgi EE; Eudailey J; Martinez DR; Yusim K; Douglas AO; Stamper L; McGuire E; LaBranche CC; Montefiori DC; Fouda GG; Gao F; Permar SR
    PLoS Pathog; 2018 Apr; 14(4):e1006944. PubMed ID: 29672607
    [TBL] [Abstract][Full Text] [Related]  

  • 23. Genetic and Phenotypic Analysis of CRF01_AE HIV-1 env Clones from Patients Residing in Beijing, China.
    Chen D; He X; Ye J; Zhao P; Zeng Y; Feng X
    AIDS Res Hum Retroviruses; 2016; 32(10-11):1113-1124. PubMed ID: 27066910
    [TBL] [Abstract][Full Text] [Related]  

  • 24. Identification of Novel Structural Determinants in MW965 Env That Regulate the Neutralization Phenotype and Conformational Masking Potential of Primary HIV-1 Isolates.
    Qualls ZM; Choudhary A; Honnen W; Prattipati R; Robinson JE; Pinter A
    J Virol; 2018 Mar; 92(5):. PubMed ID: 29237828
    [TBL] [Abstract][Full Text] [Related]  

  • 25. Neutralizing Antibody Responses Induced by HIV-1 Envelope Glycoprotein SOSIP Trimers Derived from Elite Neutralizers.
    Schorcht A; van den Kerkhof TLGM; Cottrell CA; Allen JD; Torres JL; Behrens AJ; Schermer EE; Burger JA; de Taeye SW; Torrents de la Peña A; Bontjer I; Gumbs S; Ozorowski G; LaBranche CC; de Val N; Yasmeen A; Klasse PJ; Montefiori DC; Moore JP; Schuitemaker H; Crispin M; van Gils MJ; Ward AB; Sanders RW
    J Virol; 2020 Nov; 94(24):. PubMed ID: 32999024
    [TBL] [Abstract][Full Text] [Related]  

  • 26. Characterization of neutralizing antibody responses elicited by clade A envelope immunogens derived from early transmitted viruses.
    Kraft Z; Strouss K; Sutton WF; Cleveland B; Tso FY; Polacino P; Overbaugh J; Hu SL; Stamatatos L
    J Virol; 2008 Jun; 82(12):5912-21. PubMed ID: 18400850
    [TBL] [Abstract][Full Text] [Related]  

  • 27. Association of mutations in V3/C3 domain with enhanced sensitivity of HIV-1 clade C primary envelopes to autologous broadly neutralizing plasma antibodies.
    Deshpande S; Patil S; Kumar R; Shrivastava T; Srikrishnan AK; Murugavel KG; Koff WC; Chakrabarti BK; Bhattacharya J
    Retrovirology; 2016 Jun; 13(1):41. PubMed ID: 27307004
    [TBL] [Abstract][Full Text] [Related]  

  • 28. Unique Phenotypic Characteristics of Recently Transmitted HIV-1 Subtype C Envelope Glycoprotein gp120: Use of CXCR6 Coreceptor by Transmitted Founder Viruses.
    Ashokkumar M; Aralaguppe SG; Tripathy SP; Hanna LE; Neogi U
    J Virol; 2018 May; 92(9):. PubMed ID: 29491151
    [TBL] [Abstract][Full Text] [Related]  

  • 29. Sexually-transmitted/founder HIV-1 cannot be directly predicted from plasma or PBMC-derived viral quasispecies in the transmitting partner.
    Frange P; Meyer L; Jung M; Goujard C; Zucman D; Abel S; Hochedez P; Gousset M; Gascuel O; Rouzioux C; Chaix ML;
    PLoS One; 2013; 8(7):e69144. PubMed ID: 23874894
    [TBL] [Abstract][Full Text] [Related]  

  • 30. Viral evolution in macaques coinfected with CCR5- and CXCR4-tropic SHIVs in the presence or absence of vaccine-elicited anti-CCR5 SHIV neutralizing antibodies.
    Burke B; Derby NR; Kraft Z; Saunders CJ; Dai C; Llewellyn N; Zharkikh I; Vojtech L; Zhu T; Srivastava IK; Barnett SW; Stamatatos L
    Virology; 2006 Nov; 355(2):138-51. PubMed ID: 16920175
    [TBL] [Abstract][Full Text] [Related]  

  • 31. Distinct HIV-1 entry phenotypes are associated with transmission, subtype specificity, and resistance to broadly neutralizing antibodies.
    Chikere K; Webb NE; Chou T; Borm K; Sterjovski J; Gorry PR; Lee B
    Retrovirology; 2014 Jun; 11():48. PubMed ID: 24957778
    [TBL] [Abstract][Full Text] [Related]  

  • 32. Tracing HIV-1 transmission: envelope traits of HIV-1 transmitter and recipient pairs.
    Oberle CS; Joos B; Rusert P; Campbell NK; Beauparlant D; Kuster H; Weber J; Schenkel CD; Scherrer AU; Magnus C; Kouyos R; Rieder P; Niederöst B; Braun DL; Pavlovic J; Böni J; Yerly S; Klimkait T; Aubert V; Trkola A; Metzner KJ; Günthard HF;
    Retrovirology; 2016 Sep; 13(1):62. PubMed ID: 27595568
    [TBL] [Abstract][Full Text] [Related]  

  • 33. Viremic control and viral coreceptor usage in two HIV-1-infected persons homozygous for CCR5 Δ32.
    Henrich TJ; Hanhauser E; Hu Z; Stellbrink HJ; Noah C; Martin JN; Deeks SG; Kuritzkes DR; Pereyra F
    AIDS; 2015 May; 29(8):867-76. PubMed ID: 25730507
    [TBL] [Abstract][Full Text] [Related]  

  • 34. Molecular clock of HIV-1 envelope genes under early immune selection.
    Park SY; Love TM; Perelson AS; Mack WJ; Lee HY
    Retrovirology; 2016 Jun; 13(1):38. PubMed ID: 27246201
    [TBL] [Abstract][Full Text] [Related]  

  • 35. Comparative analysis of the fusion efficiency elicited by the envelope glycoprotein V1-V5 regions derived from human immunodeficiency virus type 1 transmitted perinatally.
    Guo H; Abrahamyan LG; Liu C; Waltke M; Geng Y; Chen Q; Wood C; Kong X
    J Gen Virol; 2012 Dec; 93(Pt 12):2635-2645. PubMed ID: 22956734
    [TBL] [Abstract][Full Text] [Related]  

  • 36. Differences in molecular evolution between switch (R5 to R5X4/X4-tropic) and non-switch (R5-tropic only) HIV-1 populations during infection.
    Mild M; Kvist A; Esbjörnsson J; Karlsson I; Fenyö EM; Medstrand P
    Infect Genet Evol; 2010 Apr; 10(3):356-64. PubMed ID: 19446658
    [TBL] [Abstract][Full Text] [Related]  

  • 37. Development of a novel rhesus macaque model with an infectious R5 simian-human immunodeficiency virus encoding HIV-1 CRF08_BC env.
    Huang L; Kusagawa S; Zeng H; Yang G; Sun B; Miura T; Yang R
    J Med Primatol; 2014 Feb; 43(1):11-21. PubMed ID: 24020838
    [TBL] [Abstract][Full Text] [Related]  

  • 38. A Rare Mutation in an Infant-Derived HIV-1 Envelope Glycoprotein Alters Interprotomer Stability and Susceptibility to Broadly Neutralizing Antibodies Targeting the Trimer Apex.
    Mishra N; Sharma S; Dobhal A; Kumar S; Chawla H; Singh R; Das BK; Kabra SK; Lodha R; Luthra K
    J Virol; 2020 Sep; 94(19):. PubMed ID: 32669335
    [TBL] [Abstract][Full Text] [Related]  

  • 39. Induction of a Tier-1-Like Phenotype in Diverse Tier-2 Isolates by Agents That Guide HIV-1 Env to Perturbation-Sensitive, Nonnative States.
    Johnson J; Zhai Y; Salimi H; Espy N; Eichelberger N; DeLeon O; O'Malley Y; Courter J; Smith AB; Madani N; Sodroski J; Haim H
    J Virol; 2017 Aug; 91(15):. PubMed ID: 28490588
    [TBL] [Abstract][Full Text] [Related]  

  • 40. Variable infectivity and conserved engagement in cell-to-cell viral transfer by HIV-1 Env from Clade B transmitted founder clones.
    Li H; Chen BK
    Virology; 2019 Jan; 526():189-202. PubMed ID: 30415130
    [TBL] [Abstract][Full Text] [Related]  

    [Previous]   [Next]    [New Search]
    of 79.